Geovax Labs Inc (GOVX)
1.95
+0.08
(+4.28%)
USD |
NASDAQ |
May 23, 10:21
Geovax Labs Enterprise Value: 3.548M for May 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 22, 2024 | 3.548M |
| May 21, 2024 | 2.948M |
| May 20, 2024 | 2.994M |
| May 17, 2024 | 3.155M |
| May 16, 2024 | 3.248M |
| May 15, 2024 | 3.201M |
| May 14, 2024 | 3.155M |
| May 13, 2024 | 3.040M |
| May 10, 2024 | 2.832M |
| May 09, 2024 | 2.901M |
| May 08, 2024 | 2.994M |
| May 07, 2024 | 2.971M |
| May 06, 2024 | 3.040M |
| May 03, 2024 | 2.948M |
| May 02, 2024 | 2.509M |
| May 01, 2024 | 2.578M |
| April 30, 2024 | 2.463M |
| April 29, 2024 | 2.555M |
| April 26, 2024 | 2.509M |
| April 25, 2024 | 2.624M |
| April 24, 2024 | 2.786M |
| April 23, 2024 | 2.786M |
| April 22, 2024 | 2.809M |
| April 19, 2024 | 2.694M |
| April 18, 2024 | 2.740M |
| Date | Value |
|---|---|
| April 17, 2024 | 2.601M |
| April 16, 2024 | 2.763M |
| April 15, 2024 | 3.109M |
| April 12, 2024 | 3.178M |
| April 11, 2024 | 3.455M |
| April 10, 2024 | 3.571M |
| April 09, 2024 | 3.732M |
| April 08, 2024 | 3.617M |
| April 05, 2024 | 3.594M |
| April 04, 2024 | 3.871M |
| April 03, 2024 | 3.709M |
| April 02, 2024 | 3.663M |
| April 01, 2024 | 3.755M |
| March 28, 2024 | -1.836M |
| March 27, 2024 | -2.182M |
| March 26, 2024 | -2.205M |
| March 25, 2024 | -2.067M |
| March 22, 2024 | -2.173M |
| March 21, 2024 | -2.260M |
| March 20, 2024 | -2.325M |
| March 19, 2024 | -2.086M |
| March 18, 2024 | -2.347M |
| March 15, 2024 | -2.412M |
| March 14, 2024 | -2.021M |
| March 13, 2024 | -1.869M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-20.59M
Minimum
Jul 22 2022
57.43M
Maximum
Aug 04 2022
2.084M
Average
2.034M
Median
Oct 11 2019
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 5.958M |
| Palatin Technologies Inc | 22.90M |
| iBio Inc | 27.79M |
| Theriva Biologics Inc | -9.052M |
| Oragenics Inc | 10.89M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.850M |
| Total Expenses (Quarterly) | 5.883M |
| EPS Diluted (Quarterly) | -2.47 |
| Earnings Yield | -744.1% |
| Normalized Earnings Yield | -2405.55 |